AirSculpt Technologies (AIRS) Sidoti Micro Cap Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Micro Cap Virtual Conference summary
3 Feb, 2026Business overview and service offerings
Operates 32 corporately owned body contouring centers in the US, Canada, and UK, offering minimally invasive, patented fat removal and related services.
Services include fat removal, fat transfer, skin tightening (using Renuvion), cellulite removal, and facial fat transfer.
Procedures are performed by elite surgeons, are cash-pay only, and average $12,000–$13,000 per case.
Typical customer is affluent, 80%+ female, aged 30–50, with household income over $150,000.
Most patients return to normal activities within 24 hours post-procedure.
Financial performance and business model
2024 revenue was approximately $180 million with $21 million adjusted EBITDA; Q1 and Q2 generated $44 million revenue and $6 million EBITDA each.
Average profit per case is about $8,000, with strong cash flow and no new debt for center expansion since 2018.
Center openings cost ~$1.5 million, typically recouped within 12 months; footprint doubled from 16 to 32 centers since 2021.
De novo center growth paused for 2025 to focus on returning existing centers to same-store growth.
Debt reduced from $85 million in 2021 to $58 million by Q2 2024, funded by free cash flow and recent equity offering.
Strategic priorities and operational initiatives
Current focus areas: strengthening company culture and driving revenue through improved go-to-market strategy.
Five revenue priorities: marketing, sales conversion, new service innovation, technology upgrades, and cost efficiency.
Marketing spend reallocated to high-return channels, leading to record lead generation and >10% reduction in customer acquisition cost.
Piloting standalone skin tightening services to address demand, especially from GLP-1 medication users experiencing skin laxity.
Enhanced financing options and virtual appointments introduced to improve customer experience and conversion.
Latest events from AirSculpt Technologies
- GLP-1 procedures and new products are set to drive growth as the business stabilizes and expands.AIRS
Canaccord Genuity's 46th Annual Growth Conference - Revenue declined, net loss widened, and EBITDA margin fell amid higher marketing costs.AIRS
Q2 2026 - Positive sales momentum and new GLP-1 services drive growth, with expansion plans ahead.AIRS
Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference - Growth driven by GLP-1 service expansion, marketing, and strong clinic economics.AIRS
TD Cowen 10th Annual Future of the Consumer Conference - Growth resumes with new services, marketing, and plans for major U.S. expansion.AIRS
16th Annual LD Micro Invitational Conference - 2026 guidance targets renewed growth with expanded services, new centers, and improved margins.AIRS
Investor presentation - Q1 2026 saw stable revenue, improved net loss, and reaffirmed full-year guidance.AIRS
Q1 2026 - Q4 2025 saw improved sales and margins, with 2026 guidance reflecting renewed growth focus.AIRS
Q4 2025 - Q2 2024 revenue and profitability declined, prompting revised guidance and a CEO transition.AIRS
Q2 2024